Literature DB >> 8444216

Asymptomatic autoimmune chronic active hepatitis in a male adolescent.

S Peeters1, U Blecker, J De Valck, A Goossens, M Hautekeete, G Devis, Y Vandenplas.   

Abstract

We report a 12-year-old boy presenting with smooth muscle antibody-positive auto-immune chronic active hepatitis. Suspicion of the diagnosis arose after a routine blood test which revealed abnormal liver function tests. In spite of the presence of cirrhosis and patchy necrosis on liver biopsy, our patient never showed any clinical feature of impaired liver function. This observation demonstrates that auto-immune hepatitis may exist for a long time before clinical symptoms appear and probably explains why some cases of auto-immune hepatitis finally present as fulminant liver failure.

Entities:  

Mesh:

Year:  1993        PMID: 8444216     DOI: 10.1007/bf02072484

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.

Authors:  D Vergani; L Wells; V F Larcher; B A Nasaruddin; E T Davies; G Mieli-Vergani; A P Mowat
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

2.  Autoimmune chronic active hepatitis in a family.

Authors:  S Hodges; A Lobo-Yeo; P Donaldson; M S Tanner; D Vergani
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

3.  Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure.

Authors:  G Porta; L C Gayotto; F Alvarez
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-07       Impact factor: 2.839

4.  Duration of chronic active hepatitis and the development of cirrhosis.

Authors:  A Vegnente; V F Larcher; A P Mowat; B Portmann; R Williams
Journal:  Arch Dis Child       Date:  1984-04       Impact factor: 3.791

5.  Treatment of autoimmune chronic active hepatitis in childhood.

Authors:  G Maggiore; O Bernard; M Hadchouel; P Hadchouel; M Odievre; D Alagille
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

6.  Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.

Authors:  M Manns; G Gerken; A Kyriatsoulis; M Staritz; K H Meyer zum Büschenfelde
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

7.  Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.

Authors:  A J Stellon; J E Hegarty; B Portmann; R Williams
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

8.  Liver disease associated with anti-liver-kidney microsome antibody in children.

Authors:  G Maggiore; O Bernard; J C Homberg; M Hadchouel; F Alvarez; P Hadchouel; M Odièvre; D Alagille
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

9.  Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis.

Authors:  G Maggiore; O Bernard; M Hadchouel; D Alagille
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-08       Impact factor: 2.839

10.  Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.

Authors:  G Mieli-Vergani; A Lobo-Yeo; B M McFarlane; I G McFarlane; A P Mowat; D Vergani
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.